AB
IGMS

Amalgamated Bank’s IGM Biosciences IGMS Stock Holding History

Amalgamated Bank’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-351
Closed – – 3065
2025
Q1 		$0 Hold
351
– – ﹤0.01% 2954
2024
Q4 		$2K Hold
351
– – ﹤0.01% 2904
2024
Q3 		$6K Hold
351
– – ﹤0.01% 2699
2024
Q2 		$2K Hold
351
– – ﹤0.01% 2955
2024
Q1 		$3K Sell
351
-638
-65% -$7.39K ﹤0.01% 2823
2023
Q4 		$8K Sell
989
-104
-10% -$604 ﹤0.01% 2896
2023
Q3 		$9K Hold
1,093
– – ﹤0.01% 2913
2023
Q2 		$10K Sell
1,093
-276
-20% -$3.09K ﹤0.01% 2956
2023
Q1 		$19K Sell
1,369
-215
-14% -$4.45K ﹤0.01% 2666
2022
Q4 		$27K Hold
1,584
– – ﹤0.01% 2668
2022
Q3 		$36K Buy
1,584
+69
+5% +$1.39K ﹤0.01% 2596
2022
Q2 		$27K Buy
1,515
+180
+13% +$3.21K ﹤0.01% 2763
2022
Q1 		$36K Buy
+1,335
New +$24.9K ﹤0.01% 2612

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Amalgamated Bank's IGMS Position: Q2 2025 in Review

Amalgamated Bank sold out of IGM Biosciences (IGMS) in Q2 2025, closing a stake of 351 shares.

Amalgamated Bank first reported a position in IGMS in Q1 2022 and held it in 13 quarters. The position peaked at $36K in Q3 2022. 66 funds tracked by Wall St. Rank hold IGMS as of Q2 2025.

  • Amalgamated Bank reported no remaining IGM Biosciences position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 351 IGM Biosciences shares in Q2 2025.
  • Amalgamated Bank first reported a position in IGM Biosciences in Q1 2022 and held it in 13 quarters.
  • Amalgamated Bank's IGM Biosciences position peaked at $36K in Q3 2022.
  • 66 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.